Chase Ng
@cut_tt_chase
Followers
144
Following
130
Media
11
Statuses
62
Urology ST3 @ UCLH | RSM Urology Scholar | Clinical Research Fellow @ IP & KCL | Special interest in global uro-oncology and implementation science
London, England
Joined November 2022
Zambian national cancer registry, active global collaboration and mindful adoption of technology are 3 facilitators to build on. Our recommended priorities and strategies tiered by individual, organisational and institutional stakeholders ⬇️
0
1
2
We backed our systematic review with a consensus meeting to develop Zambia-specific cancer research capacity-building priorities and strategies. Implementation is key to decolonise research ecosystem and decentralise cancer services in Zambia. #ecancer.
1
0
5
Our figure summarising the quality indicators and patient outcome measures identified across all domains of palliative care
0
0
2
Key findings of our systematic review of quality indicators (QI) and patient outcome measures (POM) for pal care in cancer:. 1. Lack of standardisation of QIs esp in structure and outcome of care .2. A standardised QI and POM repository is required.
1
0
3
RT @IP_London: Fantastic overview of diagnostic and therapeutic strategies in radiorecurrent prostate cancer by @TaimurShah . Key takeaways….
0
5
0
RT @IP_London: Brilliant prostate cancer abstract session this morning with 4️⃣ presentations from Team IP at #BAUS25. Huge breadth covered….
0
4
0
RT @IP_London: @NikhilMayor presents outcomes from the first prospective, blinded assessment of #FCM with the #HistologScanner in #RadicalP….
0
3
0
RT @IP_London: Next up @cut_tt_chase presents the 5 year oncological outcomes of men with initial negative #ProstateCancer investigations i….
0
4
0
0
6
0
RT @IP_London: Update of #IP7PACIFIC presented by @AJWLight at #AUA25. This will be the first trial to provide definitive evidence comparin….
0
4
0
RT @IP_London: In further #RAPID data, @cut_tt_chase shows that patients discharged from a pre-biopsy MRI pathway with ASAP or HGPIN do not….
0
7
0
RT @IP_London: Building on our #IP8FLUORESCE study is #IB1LaserCOMPLETE - using ex vivo fluoresce confocal microscopy to establish muscle s….
0
5
0
Thank you Victor for highlighting this piece of work by @IP_London, which cements the oncological efficacy of the MRI-led RAPID prostate cancer diagnostic pathway. #LATP #mpMRI #AUA25.
5-year outcomes following a negative MRI or negative biopsy for suspected prostate cancer: results from 1285 patients in the rapid assessment for prostate imaging and diagnosis (RAPID) pathway. Presented by @cut_tt_chase @KingsCollegeLon. #AUA25 written coverage by @VictorPham01
0
0
0
RT @IP_London: Another big day for Team IP with 3️⃣ presentations!. 1️⃣ @LondonProstate1 (for @Connor_Urol): results of the #IP2ATLANTA RCT….
0
6
0
RT @IP_London: Powerful messages from @LondonProstate1 in the focal therapy plenary crossfire debate . Most intermediate risk cases are sui….
0
11
0
Grateful for this opportunity to share our findings with our colleagues across the Atlantic to optimise and standardise ways to diagnose csPCa while minimising over-diagnosis and redundant biopsies. Special thanks to @LondonProstate1 & @TaimurShah for mentorship and support.
Excellent podium presentation by our resident @cut_tt_chase on >1200 patients in #RAPID discharged with negative MRI or biopsy. Only 1 in 12 developed csPCa & 1 in 20 needed cancer treatment by 5 years. More evidence of the oncological efficacy of pre-biopsy MRI! #AUA25
0
2
9
RT @IP_London: Team IP is at #AUA25 with a big first day - 4️⃣ talks!. @LondonProstate1: focal therapy debate (Plenary; 08:30). @AJWLight:….
0
5
0
RT @IP_London: Thank you for engaging with us this year at the first joint #IPFTSmasterclass - see you in London in 2026! @FocalSociety htt….
0
8
0
Honoured to be a RSM scholar in the specialty I love. Excited to work with the section to make education, research and training in urology more accessible and visible in the UK and beyond! Special thanks to @RSMUrology @MattBultitude for this excellent opportunity.
1
0
18
RT @IP_London: Hurry - only a few spots remain! 🚀 Check out the agenda and register today! @FocalSociety @IP_London. 🎟️ .
0
4
0